Altamira Therapeutics Ltd. General And Administrative Expense
Altamira Therapeutics Ltd. (CYTOF) reported General And Administrative Expense of $1.24 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GeneralAndAdministrativeExpense · last filed 2025-08-29
CHF
| Period end | General And Administrative Expense 6 month | General And Administrative Expense 12 month | General And Administrative Expense 12 month as first filed |
|---|---|---|---|
| 2023-12-31 | 3.14M CHF 20-F/A · filed 2024-04-22 | ||
| 2023-06-30 | 2.17M CHF 6-K · filed 2023-09-12 | ||
| 2022-12-31 | 3.40M CHF 20-F/A · filed 2024-04-22 | 3.64M CHF 20-F · filed 2023-05-16 | |
| 2022-06-30 | 2.08M CHF 6-K · filed 2023-09-12 | ||
| 2021-12-31 | 3.67M CHF 20-F/A · filed 2024-04-22 | 4.95M CHF 20-F · filed 2022-04-12 | |
| 2021-06-30 | 3.06M CHF 6-K/A · filed 2023-08-21 | ||
| 2020-12-31 | 2.59M CHF 20-F · filed 2023-05-16 | ||
| 2020-06-30 | 1.54M CHF 6-K · filed 2021-09-08 | ||
| 2019-12-31 | 3.93M CHF 20-F · filed 2022-04-12 | ||
| 2019-06-30 | 2.80M CHF 6-K/A · filed 2020-09-17 | ||
| 2018-12-31 | 4.26M CHF 20-F · filed 2021-03-31 | ||
| 2018-06-30 | 2.46M CHF 6-K · filed 2019-08-15 | ||
| 2017-12-31 | 5.15M CHF 20-F · filed 2020-04-16 | ||
| 2016-12-31 | 5.45M CHF 20-F · filed 2019-03-14 | ||
| 2015-12-31 | 4.34M CHF 20-F · filed 2018-03-22 |
USD
| Period end | General And Administrative Expense 6 month | General And Administrative Expense 12 month |
|---|---|---|
| 2025-06-30 | $1.24M 6-K · filed 2025-08-29 | |
| 2024-12-31 | $3.20M 20-F · filed 2025-04-30 | |
| 2024-06-30 | $1.99M 6-K · filed 2025-08-29 | |
| 2023-12-31 | $3.49M 20-F · filed 2025-04-30 | |
| 2023-06-30 | $2.25M 6-K · filed 2024-09-24 | |
| 2022-12-31 | $3.56M 20-F · filed 2025-04-30 |